Thursday, November 21, 2019
8:00 AM - 8:30 AM
Registration, Welcome Coffee and Networking
8:30 AM - 8:40 AM
Chairman's Opening Address
8:40 AM - 9:10 AM

Global Patent Outlook:

  • What are the Main Challenges Facing the Global Patent System – and what can we do to Prepare for them?
  • Is the Existing IP System Fit for Purpose?
9:10 AM - 9:40 AM

Artificial Intelligence:

  • How is AI Disrupting the Patent Strategies of Life Sciences Companies?
  • What are the Likely Implications of AI on Patenting and Licensing Strategies?
  • How Should we now navigate the IP challenges
  • How to Get AI-Related Patents Past the EPO
  • How do you Develop a Trade Secrets Strategy?
  • Assessing the European Trade Secrets Directive
9:40 AM - 10:00 AM

How to get a Biologics Product Market

10:00 AM - 10:20 AM

US Patent Law Outlook: What Major Changes are on the 2020 Horizion, and will the US Ease Limits on Patent-Eligible Inventions?

10:20 AM - 10:40 AM

Best Practice in Patenting Precision Medicine

10:40 AM - 11:10 AM
Morning Coffee & Networking in the Exhibition Hall
11:10 AM - 11:40 AM

Evaluating the Impact of the latest Secondary Medical Use Case

11:40 AM - 12:00 PM

An Assessment the Impact of Recent Supplementary Protection Certificates: How can we Enhance SPC Protection?

12:00 PM - 12:20 PM

UK Focus:

  • The Doctrine of Equivalence, where are we now?
  • Understanding the Granting of Arrow Declaration: GlaxoSmithKline v Vectura
    Brexit: What Practical Steps can we make to Minimise Patent Risk for Life Sciences Companies
12:20 PM - 12:45 PM

Talking Heads: CRISPR FOCUS

  • Are we reaching the CRISPR patent end game?
  • Can we now identify the winners and losers in the CRISPR patent war?
12:45 PM - 2:00 PM
Lunch and Networking in the Exhibition Hall
2:00 PM - 2:20 PM
Roundtable Discussion Groups 
Taking part in these discussions offers delegates and speakers the opportunity to focus on topics of specific interest, within a small group. 40-45 minutes is set aside for each rotation – and delegates may choose two discussion tables. The roundtable discussion groups give delegates even more opportunity to share knowledge and opinion, and ends with a moderator round-up of key findings, providing delegates with an insight into all eight topics.
2:00 PM - 2:45 PM
Biologics & Biosimilars
CAR-T and other Immunotherapies

How do we Ensure Effective Protection of Antibodies?

IP considerations in Precision Medicine

Life Sciences Patents Open Clinic: Solving in-house counsel challenges

Navigating the CRISPR patent and licensing landscape

Patenting Robotics in the life sciences 
Prior Art: Examining the Implications of Trade Secrets Protection
Strategies in Second Medical Use Cases

Supplementary Protection Certificates

3:30 PM - 4:00 PM
Afternoon Tea and Networking in the Exhibition Hall
4:00 PM - 4:20 PM

Trademark focus: Patenting blockchain in pharma to prevent counterfeiting

4:20 PM - 4:50 PM
Innovative IP Strategies for Life Sciences: Best Practice in Managing Pharma and Biotech IP in the Age of Big Data and Precision Medicine 
4:50 PM - 5:10 PM

Enhancing Patent Strategy with Data Analytics 

5:10 PM - 5:45 PM
IP Portfolio Management: In-house Counsel Day-to-Day Challenges in Prosecuting and Enforcing Patents
5:45 PM - 7:30 PM
Chairman's Closing Remarks & Networking Drinks Reception